HIMSS Analytics has announced the release of a new Essentials Brief study focused on Imaging Techonlogy. This study is a follow up to a similar study released at the end of 2014.
HIMSS Analytics’ latest Essentials Brief provides a look at the current state of the imaging market. While study respondents indicated a high level of PACS adoption across the industry there are some areas the study highlights as potential growth opportunities. The study looks into Enterprise Image Viewing adoption and plans for future adoption, current and future imaging point of access by technology and unique voice of customer feedback around the impact of the change in payment models and accountable care will have on imaging.
“While many organizations are comfortable with their PACS imaging technology, there seems to be some opportunity on an enterprise level to get as much information as possible into the hands of physicians at the point of care,” said HIMSS Analytics Research Director, Brendan FitzGerald. “Enterprise imaging viewing capabilities across numerous technology platforms could potentially aid in that effort.”
Key findings of the Study include:
About HIMSS Analytics
HIMSS Analytics is a global healthcare advisor, providing guidance and market intelligence solutions that move the industry forward with insight to enable better health through the use of IT. As a trusted healthcare research and advisory firm, the industry depends on HIMSS Analytics’ resources, benchmarks, predictive models and assessment tools to improve decision making regarding their IT strategic roadmap and market strategy. HIMSS Analytics is uniquely positioned and differentiated through its industry focused offerings which include a Healthcare IT market intelligence tool, Healthcare IT insights and Healthcare IT benchmarks and services.
HIMSS Analytics a wholly owned subsidiary of HIMSS headquartered in Burlington Vermont, is the healthcare research and advisory firm for healthcare delivery organizations, IT companies, governmental entities, and financial, pharmaceutical, consulting and emerging technology solution partners.
Posted Under: Policy